The broad treatment expectations of migraine patients

By Kelman L.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 403-406

Springer Publishing Company

Access to resources Recommend Favorite

Improved Migraine Treatment Outcomes with Rizatriptan 10 mg Compared to Non-triptan Treatment. I-MAX Migraine Disability Assessment Program, Spain

By Torrecilla M.   Caloto M.T.   Nocea G.   Gerth W.C.  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 50-54

Informa Healthcare

Access to resources Recommend Favorite

Improved 24-Hour Migraine Quality of Life with Rizatriptan 10 mg compared to Non-Triptan Treatment. I-MAX Migraine Disability Assessment Program, Spain

By Gerth W.C.   Bertral C.   Ester F.   Castellanos A.   Caloto M.T.   Nocea G.  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 46-49

Informa Healthcare

Access to resources Recommend Favorite

acute migraine: which triptan?

By  

PRACTICAL NEUROLOGY, Vol. 4, Iss. 1, 2004-02 ,pp. : 6-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identifying Patients Who Require a Change in Their Current Acute Migraine Treatment: The Migraine Assessment of Current Therapy (Migraine-ACT) Questionnaire

By Dowson A. J.   Tepper S. J.   Baos V.   Baudet F.   D'Amico D.   Kilminster S.  

Headache Care, Vol. 2, Iss. 1, 2004-03 ,pp. : 5-10

Informa Healthcare

Access to resources Recommend Favorite